Global High Content Imaging Market Anticipated to Reach US$ 2,001.0 Million by 2030

According to a recent market study published by Growth Market Reports, titled, “Global High Content Imaging Market is segmented into by product, by application and by end-user and by Region: Size, Share, Trends and Opportunity Analysis, 2015-2030”, the market was valued at US$ 831.7Million in 2021 and is expected to grow at a growth rate of 10.5 % by the year 2030.

High content imaging (HCI) is an effective image-based model used in a wide range of fields, including biochemistry, cellular biology, molecular biology, and drug discovery. High content data extraction from an image of a biological sample is the primary objective of high content imaging systems.

High content imaging is a highly automated three-step method that is used to significantly boost imaging throughput and quantification. These three steps are: Image Acquisition, Image Processing and Image Analysis. It uses fluorescent detection, multiparameter algorithms, automated microscopy, and automated microscopy to observe & measure the interaction of therapeutics in cell populations.

Get Sample Report @ https://growthmarketreports.com/request-sample/5337

On the basis of product, the global High Content Imaging market is segregated into Instruments, Consumables, Software, and Services. Instruments are further subdivided into cell imaging & analysis systems and flow cytometers. Consumables are further subdivided into reagent & assay kits, microplates and other consumables. The instrument segment is projected to hold a significant share of the market during the forecast period, as it is a powerful tool in drug discovery & development. High-content imaging systems use automated microscopy and fluorescent detection to visualize and quantify the interaction of therapeutics in cell populations.

Based on application, the global high content imaging market is classified into primary and Secondary screening, target identification and validation, toxicity studies, compound profiling and other applications. The target identification & validation segment is expected to hold a substantial share of the market during the forecast period, as HCI delivers a functional readout in target validation studies. Toxicity studies are the investigation of the safety profile of the compound. They provide important information about the absorption, distribution, metabolism, and excretion (ADME) of the compound in the body.

In terms of end user, the global high content imaging market is segregated into pharmaceutical & biotechnology companies, academic and government institutes, contract research organization. The pharmaceutical & biotechnology company segment is projected to expand at a significant pace, as high-content imaging (HCI) is used in drug development and various clinical & preclinical studies.

The outbreak of coronavirus disease in 2019 (COVID-19) had a moderately positive impact on the global high content imaging market. Demand for high-content imaging has increased, due to the widespread use of high-content imaging in the vaccine research & drug development process during the pandemic. Pharmaceutical companies and medical researchers around the globe aim to fast-track drug discovery, development, and clinical trials in response to COVID-19, and are focusing on three key interventional strategies: repurposing of existing drugs, development of therapeutics, and development of vaccines
As per growth market reports by industry analyst divyanka sankhe, “High-content imaging (HCI) is considered as a significant tool in supportive drug discovery and development, including target identification, primary compound screening, secondary confirmation, mechanism of action (MOA) studies, and in vitro toxicology. Various HCS experimental applications have been utilized in the in vitro toxicology research field.

Supply chain management is an essential part of any business. A supply chain contains a series of steps to get products from their original state to the customers. Raw materials used for manufacturing High Content Imaging are shipped to manufacturers to be processed into final products. Quality checks are performed throughout the production process by manufacturers to ensure the quality of the product.

Key Takeaways from the Study

The players in the global high content imaging market include PerkinElmer Inc, Thermo Fisher Scientific Inc, Agilent Technologies, Inc., Charles River Laboratories, Danaher (Molecular Devices, LLC), Yokogawa Electric Corporation, Miltenyi Biotec, Nikon Corporation (Nikon Instruments Inc), Zeiss Group (arivis AG), Aligned Genetics, Inc.

Target Audience

• Supply-side: Manufacturer and distributors.
• Demand Side: Pharmaceutical & Biotechnology Companies, Academic and Government Institutes, Contract Research Organization.
• Regulatory Side: Approved regulatory bodies.
• Associations and Industry Bodies: USFDA and other regulatory bodies.